Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2012

Jun 5, 2012

31971_dirs_2012-06-05_bb75c2f9-d06e-45de-851f-179fb2aaf9ed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-06-01

Reporting Person: CORASANTI EUGENE R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-06-01 Common Stock M 200 Acquired 68150 Direct
2012-06-01 Common Stock F 53 $26.09 Disposed 68097 Direct
2012-06-01 Common Stock M 200 Acquired 68297 Direct
2012-06-01 Common Stock F 53 $26.09 Disposed 68244 Direct
2012-06-01 Common Stock M 1000 Acquired 69244 Direct
2012-06-01 Common Stock F 265 $26.09 Disposed 68979 Direct
2012-06-01 Common Stock M 1000 Acquired 69979 Direct
2012-06-01 Common Stock F 265 $26.09 Disposed 69714 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-06-01 Rsus (restricted Stock Units) $0 M 200 Disposed 2018-06-01 Common Stock (200) Direct
2012-06-01 Rsus (restricted Stock Units) $0 M 200 Disposed 2019-06-01 Common Stock (200) Direct
2012-06-01 Rsus (restricted Stock Units) $0 M 1000 Disposed 2020-06-01 Common Stock (1000) Direct
2012-06-01 Rsus (restricted Stock Units) $0 M 1000 Disposed 2021-06-01 Common Stock (1000) Direct
2012-06-01 Rsus (restricted Stock Units) $0 A 5000 Acquired 2022-06-01 Common Stock (5000) Direct
2012-06-01 Sars (Stock Appreciation Rights) $26.09 A 2500 Acquired 2022-06-01 Common Stock (2500) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.